Opioid-Induced Nausea and Vomiting: What the Oncology Nurse Should Know
Up to 40% of patients with cancer who take opioids experience nausea and vomiting.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
2 Clarke Drive Cranbury, NJ 08512